Immuron Limited
(ASX:IMC) has announced that its pharmaceuticals can now be bought in China on the website JD.com.
The company’s e-commerce partner, QBID, has placed its first orders for Travelan (a traveller’s diarrhoea medication) and Protectyn (a natural dietary supplement).
Immuron says that there is high demand for Australian and NZ products from China.
This meant that it was critical for Immuron to meet an aggressive launch timeline so that its products were available to Chinese customers.
Immuron reported a net loss of $1.92 million at 31 December 2015.
